Session on Psychedelics Sure to Be Enlightening - Nick Zagorski (Psychiatric News, 2021)

The acute effects of classic psychedelics on memory in humans. - Healy CJ (Psychopharmacology, 2021)

P.214 (Sub)acute effects of psilocybin on creative cognition: a double-blind, placebo-controlled experimental study - Natasha L. Mason; Kim P. C. Kuypers; Johannes T. Reckweg; Felix Müller; Johannes G. Ramaekers (European Neuropsychopharmacology, 2021)

Classic psychedelic coadministration with lithium, but not lamotrigine, is associated with seizures: an analysis of online psychedelic experience reports - Nayak S; Gukasyan N; Barrett FS; Erowid E; Erowid F; Griffiths RR. (PsyArXiv, 2021)

Therapeutic Potential of Psychedelics in Treatment of Psychiatric Disorders, Part 2 - Avinash Hosanagar; Joseph Cusimano; Rajiv Radhakrishnan (The Journal of Clinical Psychiatry, 2021)

Chemistry and Toxicology of Major Bioactive Substances in Mushrooms. - Patocka J; Wu R; Nepovimova E; Valis M; Wu W; Kuca K (International journal of molecular sciences, 2021)

Psychedelic Strategies; Alternative Phenomenologies, Translations, and Representations of the Human Body in Relation to Interior Space - Emily Pellicano (Journal of Interior Design, 2021)

How to Change Your Mind: What the New Science of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression, and Transcendence - Peter G. Brindley (Anesthesia & Analgesia, 2021)

Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo - Shao L; Liao C; Gregg I; Davoudian PA; Savalia NK; Delagarza K; Kwan AC. (bioRxiv, 2021)

Psilocin acutely disrupts sleep and affects local but not global sleep homeostasis in laboratory mice - Thomas CW; Blanco-Duque C; Bréant B; Goodwin GM; Sharp T; Bannerman DM; Vyazovskiy VV. (bioRxiv, 2021)

Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experience - Madsen MK; Stenbæk DS; Arvidsson A; Armand S; Marstrand-Joergensen MR; Johansen SS; Linnet K; Ozenne B; Knudsen GM; Fisher PM. (bioRxiv, 2021)

Use of psilocybin (“mushrooms”) among US adults: 2015-2018 - R. Andrew Yockey; Keith A. King (Journal of Psychedelic Studies, 2021)

Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine. - De Gregorio D; Aguilar-Valles A; Preller KH; Heifets BD; Hibicke M; Mitchell J; Gobbi G (The Journal of neuroscience: the official journal of the Society for Neuroscience, 2021)

Psilocybin Treatment for Mental Health Gets Legal Framework - Zoe Cormier (Scientific American, 2021)

Stability of psilocybin and its four analogs in the biomass of the psychotropic mushroom Psilocybe cubensis. - Gotvaldová K; Hájková K; Borovička J; Jurok R; Cihlářová P; Kuchař M (Drug testing and analysis, 2021)

Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern-era clinical studies. - Andersen KAA; Carhart-Harris R; Nutt DJ; Erritzoe D (Acta psychiatrica Scandinavica, 2021)

Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants. - Galvão-Coelho NL; Marx W; Gonzalez M; Sinclair J; de Manincor M; Perkins D; Sarris J (Psychopharmacology, 2021)

Psilacetin derivatives: fumarate salts of the methyl-ethyl, methyl-allyl and diallyl variants of the psilocin prodrug - Pham Duyen N. K.; Chadeayne Andrew R.; Golen James A.; Manke David R. (Acta Crystallographica Section E Crystallographic Communications, 2021)

Development and validation of an LC-MS/MS method for the bioanalysis of psilocybin’s main metabolites, psilocin and 4-hydroxyindole-3-acetic acid, in human plasma - Kolaczynska Karolina E.; Liechti Matthias E.; Duthaler Urs (Journal of Chromatography B, 2021)

Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals - McCulloch DE; Madsen MK; Stenbæk DS; Kristiansen S; Ozenne B; Jensen PS; Knudsen GM; Fisher PM. (bioRxiv, 2021)

Behandeling met psilocybine - Joost J. Breeksema; Martijn H B Koolen; Metten Somers; Robert A. Schoevers (Data Archiving and Networked Services (DANS), 2021)

[Treatment with psilocybin: applications for patients with psychiatric disorders]. - Breeksema JJ; Koolen MHB; Somers M; Schoevers RA (Nederlands tijdschrift voor geneeskunde, 2021)

A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT Receptor Density in the Pig Brain. - Raval NR; Johansen A; Donovan LL; Ros NF; Ozenne B; Hansen HD; Knudsen GM (International journal of molecular sciences, 2021)

Psilocybin, Spirituality, and Palliative Care: Research and Implications - Anthony P. Bossis (Alternative and Complementary Therapies, 2021)

Narratives of the mystical among users of psychedelics - Willy Pedersen; Heith Copes; Liridona Gashi (Acta Sociologica, 2021)

Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS Survivors - Joshua Woolley (ClinicalTrials.gov, 2021)

Draft Genome Sequence of the Termite-Associated "Cuckoo Fungus," () sp. TMB Strain TB5. - Konkel Z; Scott K; Slot JC (Microbiology resource announcements, 2021)

POTENCIAL USO DA PSILOCIBINA NO TRATAMENTO DA DEPRESSÃO: UMA REVISÃO / POTENTIAL USE OF PSILOCYBIN IN THE DEPRESSION TREATMENT: A REVIEW - Vagner Fagnani Linartevichi; Matheus Gonzales Froza; Rafael de Morais Cury; Francisney Pinto do Nascimento (Brazilian Journal of Development, 2021)

Anti-Inflammatory Effects of Four Psilocybin-Containing Magic Mushroom Water Extracts in vitro on 15-Lipoxygenase Activity and on Lipopolysaccharide-Induced Cyclooxygenase-2 and Inflammatory Cytokines in Human U937 Macrophage Cells. - Nkadimeng SM; Steinmann CML; Eloff JN (Journal of inflammation research, 2021)

Referee report. For: Development of a physiologically based pharmacokinetic (PBPK) model of psilocybin and psilocin from magic mushroom in rats and humans [version 1; peer review: 1 not approved] - Michael W. Dzierlenga (Faculty of 1000 Research Ltd, 2021)

Referee report. For: Development of a physiologically based pharmacokinetic (PBPK) model of psilocybin and psilocin from magic mushroom in rats and humans [version 1; peer review: 1 approved with reservations, 1 not approved] - Quoc Ba Tran (Faculty of 1000 Research Ltd, 2021)

Referee report. For: A whole genome atlas of 81 Psilocybe genomes as a resource for psilocybin production. [version 1; peer review: 1 not approved] - Bryn T. M. Dentinger; Alexander J. Bradshaw (Faculty of 1000 Research Ltd, 2021)

Exploring moral bio-enhancement through psilocybin facilitated prosocial effects - Victor Lange; Marie; Sidsel (Research at the University of Copenhagen (University of Copenhagen), 2021)

"It kind of polishes all your flaws away": long-term experiences with psilocybin mushrooms and the influence of set and setting - Danielle Nicole Daniel (Cal Poly Humboldt Digital Commons, 2021)

Unmet need in depression: Psilocybin, a breakthrough treatment option - Yogesh Kumar Chahar (International Journal of Advanced Research in Medicine, 2021)

Preclinical Behavioral Assessment of Chronic, Intermittent Low-Dose Psilocybin in Rodent Models of Depression and Anxiety - Harmony I. Risca (Western Michigan University ScholarWorks, 2021)

Psychedelics and Psychedelic-Assisted Psychotherapy. - Reiff CM; Richman EE; Nemeroff CB; Carpenter LL; Widge AS; Rodriguez CI; Kalin NH; McDonald WM; Work Group on Biomarkers; Novel Treatments; a Division of the American Psychiatric Association Council of Research (Focus (American Psychiatric Publishing), 2021)

Chemical Composition of Traditional and Analog Ayahuasca. - Kaasik H; Souza RCZ; Zandonadi FS; Tófoli LF; Sussulini A (Journal of psychoactive drugs, 2021)

Efficacy of Psychoactive Drugs for the Treatment of Posttraumatic Stress Disorder: A Systematic Review of MDMA, Ketamine, LSD and Psilocybin. - Varker T; Watson L; Gibson K; Forbes D; O'Donnell ML (Journal of psychoactive drugs, 2021)

Making "bad trips" good: How users of psychedelics narratively transform challenging trips into valuable experiences. - Gashi L; Sandberg S; Pedersen W (The International journal on drug policy, 2021)

Exploratory Controlled Study of the Migraine-Suppressing Effects of Psilocybin. - Schindler EAD; Sewell RA; Gottschalk CH; Luddy C; Flynn LT; Lindsey H; Pittman BP; Cozzi NV; D'Souza DC (Neurotherapeutics: the journal of the American Society for Experimental NeuroTherapeutics, 2021)

Taking Different Roads: l-Tryptophan as the Origin of Psilocybe Natural Products. - Lenz C; Sherwood A; Kargbo R; Hoffmeister D (ChemPlusChem, 2021)

Effects of a single dose of psilocybin on behaviour, brain 5-HT receptor occupancy and gene expression in the pig. - Donovan LL; Johansen JV; Ros NF; Jaberi E; Linnet K; Johansen SS; Ozenne B; Issazadeh-Navikas S; Hansen HD; Knudsen GM (European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology, 2021)

Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms. - Inserra A; De Gregorio D; Gobbi G (Pharmacological reviews, 2021)

How ecstasy and psilocybin are shaking up psychiatry. - Tullis P (Nature, 2021)

5-HT and 5-HT receptors as potential targets for the treatment of nicotine use and dependence. - Higgins GA; Sellers EM (Progress in brain research, 2021)

Psychedelic Medicines in Major Depression: Progress and Future Challenges. - Bouso JC; Ona G; Dos Santos RG; Hallak JEC (Advances in experimental medicine and biology, 2021)

People of color in North America report improvements in racial trauma and mental health symptoms following psychedelic experiences. - Williams MT; Davis AK; Xin Y; Sepeda ND; Grigas PC; Sinnott S; Haeny AM (Drugs (Abingdon, England), 2021)

A Trip Through Employment Law: Protecting Therapeutic Psilocybin Users in the Workplace. - Sheppard B (Journal of law and health, 2021)

Development and Evaluation of a Therapist Training Program for Psilocybin Therapy for Treatment-Resistant Depression in Clinical Research. - Tai SJ; Nielson EM; Lennard-Jones M; Johanna Ajantaival RL; Winzer R; Richards WA; Reinholdt F; Richards BD; Gasser P; Malievskaia E (Frontiers in psychiatry, 2021)

What is the clinical evidence on psilocybin for the treatment of psychiatric disorders? A systematic review. - Castro Santos H; Gama Marques J (Porto biomedical journal, 2021)

The Evolved Psychology of Psychedelic Set and Setting: Inferences Regarding the Roles of Shamanism and Entheogenic Ecopsychology. - Winkelman MJ (Frontiers in pharmacology, 2021)

Low Doses of Psilocybin and Ketamine Enhance Motivation and Attention in Poor Performing Rats: Evidence for an Antidepressant Property. - Higgins GA; Carroll NK; Brown M; MacMillan C; Silenieks LB; Thevarkunnel S; Izhakova J; Magomedova L; DeLannoy I; Sellers EM (Frontiers in pharmacology, 2021)

The Use of Classic Hallucinogens/Psychedelics in a Therapeutic Context: Healthcare Policy Opportunities and Challenges. - Dos Santos RG; Bouso JC; Rocha JM; Rossi GN; Hallak JE (Risk management and healthcare policy, 2021)

Psychedelic Harm Reduction and Integration: A Transtheoretical Model for Clinical Practice. - Gorman I; Nielson EM; Molinar A; Cassidy K; Sabbagh J (Frontiers in psychology, 2021)

Long-term Amelioration of OCD Symptoms in a Patient with Chronic Consumption of Psilocybin-containing Mushrooms. - Lugo-Radillo A; Cortes-Lopez JL (Journal of psychoactive drugs, 2021)

Persistent Tinnitus after Inhaled N,N-dimethyltryptamine (DMT). - Diab H; Malcolm B (Journal of psychoactive drugs, 2021)

A draft reference assembly of the genome. - McKernan K; Kane LT; Crawford S; Chin CS; Trippe A; McLaughlin S (F1000Research, 2021)

Psilocybin: From Serendipity to Credibility? - Rucker JJ; Young AH (Frontiers in psychiatry, 2021)

Effects of Ayahuasca on the Recognition of Facial Expressions of Emotions in Naive Healthy Volunteers: A Pilot, Proof-of-Concept, Randomized Controlled Trial. - Rocha JM; Rossi GN; de Lima Osório F; Bouso JC; de Oliveira Silveira G; Yonamine M; Campos AC; Bertozi G; Cecílio Hallak JE; Dos Santos RG (Journal of clinical psychopharmacology, 2021)

A "Trip" to the Intensive Care Unit: An Intravenous Injection of Psilocybin. - Giancola NB; Korson CJ; Caplan JP; McKnight CA (Journal of the Academy of Consultation-Liaison Psychiatry, 2021)

Cross-Sectional Associations Between Lifetime Use of Psychedelic Drugs and Psychometric Measures During the COVID-19 Confinement: A Transcultural Study. - Révész D; Ona G; Rossi GN; Rocha JM; Dos Santos RG; Hallak JEC; Alcázar-Córcoles MÁ; Bouso JC (Frontiers in psychiatry, 2021)

Sustained, Multifaceted Improvements in Mental Well-Being Following Psychedelic Experiences in a Prospective Opportunity Sample. - Mans K; Kettner H; Erritzoe D; Haijen ECHM; Kaelen M; Carhart-Harris RL (Frontiers in psychiatry, 2021)

Psychedelic Psychiatry and the Consult-Liaison Psychiatrist: A Primer. - Barnett BS; Greer GR (Journal of the Academy of Consultation-Liaison Psychiatry, 2021)

Does Psychedelic Therapy Have a Transdiagnostic Action and Prophylactic Potential? - Kočárová R; Horáček J; Carhart-Harris R (Frontiers in psychiatry, 2021)

Effects of Ayahuasca on Personality: Results of Two Randomized, Placebo-Controlled Trials in Healthy Volunteers. - Mendes Rocha J; Rossi GN; Osório FL; Bouso Saiz JC; Silveira GO; Yonamine M; Crevelin EJ; Queiroz ME; Cecílio Hallak JE; Dos Santos RG (Frontiers in psychiatry, 2021)

Examining the Potential Synergistic Effects Between Mindfulness Training and Psychedelic-Assisted Therapy. - Eleftheriou ME; Thomas E (Frontiers in psychiatry, 2021)

Spontaneous Spiritual Awakenings: Phenomenology, Altered States, Individual Differences, and Well-Being. - Corneille JS; Luke D (Frontiers in psychology, 2021)

Exposure-Response Analysis to Assess the Concentration-QTc Relationship of Psilocybin/Psilocin - Dahmane Elyes; Hutson Paul R.; Gobburu Jogarao V. S. (Clinical Pharmacology in Drug Development, 2021)

Plasma psilocin critically determines behavioral and neurobiological effects of psilocybin - Madsen Martin K.; Knudsen Gitte M. (Neuropsychopharmacology, 2021)

Trends in the Top-Cited Articles on Classic Psychedelics. - Lawrence DW; Sharma B; Griffiths RR; Carhart-Harris R (Journal of psychoactive drugs, 2021)

Psychedelic-Assisted Psychotherapy After COVID-19: The Therapeutic Uses of Psilocybin and MDMA for Pandemic-Related Mental Health Problems. - Argento E; Christie D; Mackay L; Callon C; Walsh Z (Frontiers in psychiatry, 2021)

Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics. - de Vos CMH; Mason NL; Kuypers KPC (Frontiers in psychiatry, 2021)

Neuropsychological Functioning in Users of Serotonergic Psychedelics - A Systematic Review and Meta-Analysis. - Basedow LA; Riemer TG; Reiche S; Kreutz R; Majić T (Frontiers in pharmacology, 2021)

The Effects of Tryptamine Psychedelics in the Brain: A meta-Analysis of Functional and Review of Molecular Imaging Studies. - Castelhano J; Lima G; Teixeira M; Soares C; Pais M; Castelo-Branco M (Frontiers in pharmacology, 2021)

Psychedelics, Sociality, and Human Evolution. - Rodríguez Arce JM; Winkelman MJ (Frontiers in psychology, 2021)

Psychedelics and Other Psychoplastogens for Treating Mental Illness. - Vargas MV; Meyer R; Avanes AA; Rus M; Olson DE (Frontiers in psychiatry, 2021)

Study Protocol for "Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study". - Spriggs MJ; Douglass HM; Park RJ; Read T; Danby JL; de Magalhães FJC; Alderton KL; Williams TM; Blemings A; Lafrance A; Nicholls DE; Erritzoe D; et al. (Frontiers in psychiatry, 2021)

Translating Psychedelic Therapies From Clinical Trials to Community Clinics: Building Bridges and Addressing Potential Challenges Ahead. - Williams ML; Korevaar D; Harvey R; Fitzgerald PB; Liknaitzky P; O'Carroll S; Puspanathan P; Ross M; Strauss N; Bennett-Levy J (Frontiers in psychiatry, 2021)

A Spectrum of Selves Reinforced in Multilevel Coherence: A Contextual Behavioural Response to the Challenges of Psychedelic-Assisted Therapy Development. - Whitfield HJ (Frontiers in psychiatry, 2021)

H Nuclear Magnetic Resonance: A Future Approach to the Metabolic Profiling of Psychedelics in Human Biofluids? - Vilca-Melendez S; Uthaug MV; Griffin JL (Frontiers in psychiatry, 2021)

Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective. - Kelly JR; Gillan CM; Prenderville J; Kelly C; Harkin A; Clarke G; O'Keane V (Frontiers in psychiatry, 2021)

Erratum: A Spectrum of Selves Reinforced in Multilevel Coherence: A Contextual Behavioural Response to the Challenges of Psychedelic-Assisted Therapy Development. - Frontiers Production Office (Frontiers in psychiatry, 2021)

Psychedelic Mushrooms in the USA: Knowledge, Patterns of Use, and Association With Health Outcomes. - Matzopoulos R; Morlock R; Morlock A; Lerer B; Lerer L (Frontiers in psychiatry, 2021)

Studies on Psilocybin Drug Derivatives Against SARS-CoV-2 and Cytokine Storm of Human Interleukin-6 Receptor. - Khan FI; Hassan F; Lai D (Frontiers in immunology, 2021)

Human Cortical Serotonin 2A Receptor Occupancy by Psilocybin Measured Using [C]MDL100,907 Dynamic PET and a Resting-State fMRI-Based Brain Parcellation. - Barrett FS; Zhou Y; Carbonaro TM; Roberts JM; Smith GS; Griffiths RR; Wong DF (Frontiers in neuroergonomics, 2021)

Evaluating the Potential Use of Serotonergic Psychedelics in Autism Spectrum Disorder. - Markopoulos A; Inserra A; De Gregorio D; Gobbi G (Frontiers in pharmacology, 2021)

Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression. - Murphy R; Kettner H; Zeifman R; Giribaldi B; Kartner L; Martell J; Read T; Murphy-Beiner A; Baker-Jones M; Nutt D; Erritzoe D; Watts R; et al. (Frontiers in pharmacology, 2021)

The Effect of Psilocybin on Personality - Ravital LaBua (CUNY Academic Works (City University of New York), 2020)

We Need a Cole Memorandum for Magic Mushrooms - Robert A. Mikos (SSRN Electronic Journal, 2020)

Waiting for a Miracle: Medical Psilocybin and Mdma under 'Right to Try' - Jacob Evans (SSRN Electronic Journal, 2020)

Patents on Psychedelics: The Next Legal Battlefront of Drug Development - Mason Marks; I. Glenn Cohen (SSRN Electronic Journal, 2020)

Trip Reports: Exploring the Experience of Psychedelic Intoxication - Jonas Bååth; Johan Nordgren (Lund University Publications (Lund University), 2020)

Set and Setting: A Randomized Study of Different Musical Genres in Supporting Psychedelic Therapy - Strickland JC; Garcia-Romeu A; Johnson M. (PsyArXiv, 2020)

Effects and safety of Psilocybe cubensis and Panaeolus cyanescens magic mushroom extracts on endothelin-1-induced hypertrophy and cell injury in cardiomyocytes. - Nkadimeng SM; Steinmann CML; Eloff JN (Scientific reports, 2020)

The Effects of Daytime Psilocybin Administration on Sleep: Implications for Antidepressant Action - Dudysová Daniela; Janku Karolina; Smotek Michal; Saifutdinova Elizaveta; Koprivova Jana; Bušková Jitka; Mander Bryce Anthony; Brunovský Martin; Zach Peter; Korčák Jakub; Andrashko Veronika; Viktorinová Michaela; et al. (Institutional Repositories DataBase (IRDB), 2020)

DARK Classics in Chemical Neuroscience: NBOMes. - Poulie CBM; Jensen AA; Halberstadt AL; Kristensen JL (ACS chemical neuroscience, 2020)

Describing the Unspeakable: Psychedelic Communication Technologies and the Development of a Posthuman Language - Benjamin Dueck (Journal of Posthuman Studies, 2020)

Effects of Serotonin Transporter Inhibition on the Subjective Response to Psilocybin in Healthy Subjects - University Hospital; Basel; Switzerland (ClinicalTrials.gov, 2020)

Historic psychedelic drug trials and the treatment of anxiety disorders. - Weston NM; Gibbs D; Bird CIV; Daniel A; Jelen LA; Knight G; Goldsmith D; Young AH; Rucker JJ (Depression and anxiety, 2020)

P300-mediated modulations in self-other processing under psychedelic psilocybin are related to connectedness and changed meaning: A window into the self-other overlap. - Smigielski L; Kometer M; Scheidegger M; Stress C; Preller KH; Koenig T; Vollenweider FX (Human brain mapping, 2020)

The emerging role of psilocybin and MDMA in the treatment of mental illness. - Gill H; Gill B; Chen-Li D; El-Halabi S; Rodrigues NB; Cha DS; Lipsitz O; Lee Y; Rosenblat JD; Majeed A; Mansur RB; Nasri F; et al. (Expert review of neurotherapeutics, 2020)

Potential safety, benefits, and influence of the placebo effect in microdosing psychedelic drugs: A systematic review. - Ona G; Bouso JC (Neuroscience and biobehavioral reviews, 2020)

Psychedelic Psychiatry: Preparing for Novel Treatments Involving Altered States of Consciousness. - Holoyda B (Psychiatric services (Washington, D.C.), 2020)

Post-acute psychological effects of classical serotonergic psychedelics: a systematic review and meta-analysis. - Goldberg SB; Shechet B; Nicholas CR; Ng CW; Deole G; Chen Z; Raison CL (Psychological medicine, 2020)

A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT2A Receptor Density in the Pig Brain - Raval NR; Johansen A; Donovan LL; Ros NF; Ozenne B; Hansen HD; Knudsen GM. (Preprints.org, 2020)

UHPLC-MS/MS method for simultaneously detecting 16 tryptamines and their metabolites in human hair and applications to real forensics cases. - Shi Y; Wang R; Yuan S; Qiang H; Shen M; Shen B; Drummer OH; Yu Z; Zhao Y; Xiang P (Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2020)

MDMA-induced changes in within-network connectivity contradict the specificity of these alterations for the effects of serotonergic hallucinogens - Felix Müller; Friederike Holze; Patrick C. Dolder; Laura Ley; Patrick Vizeli; Alain Soltermann; Matthias E. Liechti; Stefan Borgwardt (Neuropsychopharmacology, 2020)

Snapshot of narcotic drugs and psychoactive substances in Kuwait: a qualitative analysis of illicit drugs and their associated mortality in Kuwait from 2015 to 2018 - Al-Matrouk A; Al-Hasan M; Naqi HA; Al-Abkal N; Mohammed H; Haider M; Al-Shammeri D; Bojbarah H. (Research Square, 2020)

Advancing elite athlete mental health treatment with psychedelic-assisted psychotherapy - Courtney C. Walton; Paul Liknaitzky (Journal of Applied Sport Psychology, 2020)

Beyond the Self and Back: Neuropharmacological Mechanisms Underlying the Dissolution of the Self - University of Zurich (ClinicalTrials.gov, 2020)

P.804A single dose of psilocybin increases synaptic density and decreases 5-HT2A receptor density in the pig brain - Nakul Ravi Raval; Annette Johansen; Lene Lundgaard Donovan; Nelson Ros; Brice Ozenne; Hanne D. Hansen; Gitte M. Knudsen (European Neuropsychopharmacology, 2020)

Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin. - Mason NL; Kuypers KPC; Müller F; Reckweg J; Tse DHY; Toennes SW; Hutten NRPW; Jansen JFA; Stiers P; Feilding A; Ramaekers JG (Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology, 2020)

P.227 Psilocybin induces resting-state functional connectivity changes, which correlate with plasma psilocin levels and psychedelic experience - Madsen M.K.; Stenbæk D.S.; Ozenne B.; Armand S.; Marstrand-Jørgensen M.R.; Arvidsson A.; Johansen S.S.; Linnet K.; Knudsen G.M.; Fisher P.M. (European Neuropsychopharmacology, 2020)

A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy - Luoma JB; Chwyl C; Bathje G; Davis AK; Lancelotta RL. (PsyArXiv, 2020)

Systematic Error for Extraction of Controlled Substances from Plant/Fungal Materials. - Nagy J; Veress T (Journal of chromatographic science, 2020)

Polypharmacology or "Pharmacological Promiscuity" In Psychedelic Research: What Are We Missing? - Ona GS; Dos Santos RG; Hallak JEC; Bouso JC (ACS chemical neuroscience, 2020)

Effects of Psilocybin on Anxiety and Psychosocial Distress in Cancer Patients - NYU Langone Health (ClinicalTrials.gov, 2020)

The use of psychedelics in the treatment of disorders of consciousness. An interview with Olivia Gosseries by Charlotte Martial. - Olivia Gosseries; Charlotte Martial (Open Repository and Bibliography (University of Liège), 2020)

Turn On, Tune In, Drop In: Psychedelics, Creativity and Entrepreneurship - Lawrence Silver (American Journal of Management, 2020)

The Role of Psychedelics and Counseling in Mental Health Treatment - Russ Curtis; Lisen C. Roberts; Elizabeth Graves; Heather Thompson Rainey; D. D. Wynn; Daphne Krantz; Verena Wieloch (Journal of Mental Health Counseling, 2020)

Psilocybin: from ancient magic to modern medicine. - Nichols DE (The Journal of antibiotics, 2020)

Efficacy of psychedelic treatments on depressive symptoms: A meta-analysis. - Romeo B; Karila L; Martelli C; Benyamina A (Journal of psychopharmacology (Oxford, England), 2020)

Synthesis and characterization of high-purity N,N-dimethyltryptamine hemifumarate for human clinical trials. - Cozzi NV; Daley PF (Drug testing and analysis, 2020)

Modulatory effects of ayahuasca on personality structure in a traditional framework. - Netzband N; Ruffell S; Linton S; Tsang WF; Wolff T (Psychopharmacology, 2020)

Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study. - Anderson BT; Danforth A; Daroff PR; Stauffer C; Ekman E; Agin-Liebes G; Trope A; Boden MT; Dilley PJ; Mitchell J; Woolley J (EClinicalMedicine, 2020)

Psilocybin-assisted group therapy: A new hope for demoralization. - Hendricks PS (EClinicalMedicine, 2020)

Immunochemical monitoring of psilocybin and psilocin to identify hallucinogenic mushrooms - Morita Izumi; Oyama Hiroyuki; Kiguchi Yuki; Oguri Akari; Fujimoto Natsumi; Takeuchi Atsuko; Tanaka Rie; Ogata Jun; Kikura-Hanajiri Ruri; Kobayashi Norihiro (Journal of Pharmaceutical and Biomedical Analysis, 2020)

Wait for the Science Before Widespread Use of Psilocybin - Nicole Harrington Cirino (Psychiatric News, 2020)

Drugs in therapy. LSD, MDMA, marijuana, psilocybin, designer drugs and its potential in modern medicine. - Agata Tadeja (Farmacja Polska, 2020)

Cannabis as entheogen: survey and interview data on the spiritual use of cannabis. - Johnstad PG (Journal of cannabis research, 2020)

Classic Psychedelics as a Psychotherapeutic Aid in the Treatment of Stimulant Use Disorder: a Case Report - Shevaugn Johnson; Quentin Black (International Journal of Mental Health and Addiction, 2020)

Psilocybin rescues sociability deficits in an animal model of autism - Mollinedo-Gajate I; Song C; Sintes-Rodriguez M; Whelan T; Soula A; Selimbeyoglu A; Hurley S; Knöpfel T. (bioRxiv, 2020)

Total Recall: Lateral Habenula and Psychedelics in the Study of Depression and Comorbid Brain Disorders. - Vitkauskas M; Mathuru AS (International journal of molecular sciences, 2020)

Psilocybin as a New Approach to Treat Depression and Anxiety in the Context of Life-Threatening Diseases-A Systematic Review and Meta-Analysis of Clinical Trials. - Vargas AS; Luís Â; Barroso M; Gallardo E; Pereira L (Biomedicines, 2020)

Psilocybin Can Diminish Depression. - Jones TK; Lippmann S (The primary care companion for CNS disorders, 2020)

Psilocybin acutely alters the functional connectivity of the claustrum with brain networks that support perception, memory, and attention. - Barrett FS; Krimmel SR; Griffiths RR; Seminowicz DA; Mathur BN (NeuroImage, 2020)

Compassionate use of psychedelics. - Greif A; Šurkala M (Medicine, health care, and philosophy, 2020)

Psilocybin occasioned mystical-type experiences. - James E; Robertshaw TL; Hoskins M; Sessa B (Human psychopharmacology, 2020)

Perceived harm, motivations for use and subjective experiences of recreational psychedelic 'magic' mushroom use. - Roberts CA; Osborne-Miller I; Cole J; Gage SH; Christiansen P (Journal of psychopharmacology (Oxford, England), 2020)

Psychedelic Treatments for Psychiatric Disorders: A Systematic Review and Thematic Synthesis of Patient Experiences in Qualitative Studies. - Breeksema JJ; Niemeijer AR; Krediet E; Vermetten E; Schoevers RA (CNS drugs, 2020)

The Psilocin (4-hydroxy-N,N-dimethyltryptamine) and Bufotenine (5-hydroxy-N,N-dimethyltryptamine) Case: Ensuring the Correct Isomer has Been Identified - Mishraki-Berkowitz Tehila; Kochelski Esti; Kavanagh Pierce; O'Brien John; Dunne Clodagh; Talbot Brian; Ennis Patricia; Wolf Udi (Ehud) (Journal of Forensic Sciences, 2020)

Phytochemical, Cytotoxicity, Antioxidant and Anti-Inflammatory Effects of Magic Mushroom. - Nkadimeng SM; Nabatanzi A; Steinmann CML; Eloff JN (Plants (Basel, Switzerland), 2020)

Case Report: Resolution of Rheumatoid Arthritis in a Patient Consuming Psilocybin Mushrooms - Lin Denise S (Journal of Healthcare, 2020)

Delayed Anxiolytic-Like Effects of Psilocybin in Male Mice Are Supported by Acute Glucocorticoid Release - Jones NT; Zahid Z; Grady SM; Sultan ZW; Zheng Z; Banks MI; Wenthur CJ. (bioRxiv, 2020)

Oregon's Pioneering Effort to Enact State Law to Allow Access to Psilocybin - James D. Tucker (SSRN Electronic Journal, 2020)

The Yale Manual for Psilocybin-Assisted Therapy of Depression (using Acceptance and Commitment Therapy as a Therapeutic Frame) - Guss J; Krause R; Sloshower J. (PsyArXiv, 2020)

The Yale Manual for Psilocybin-Assisted Therapy of Depression (using Acceptance and Commitment Therapy as a Therapeutic Frame) - Jeffrey Guss; Robert Krause; Jordan Sloshower (PsyArXiv, 2020)

Psilocybin as an Effective Treatment for Patients with Life-Threatening Cancer and Psychological Distress: A Critically Appraised Topic - Callie Munson; Elyse Sunshine (Pacific University CommonKnowledge, 2020)

Confirmatory factor analysis of Mystical Experience in Freediving as a recreative way to higher efficiency in sport performance and planet saving and money making - Mitina O; Mirsaidov M; Molchanova N; Tutrin A. (PsyArXiv, 2020)

Confirmatory factor analysis of Mystical Experience in Freediving as a recreative way to higher efficiency in sport performance and planet saving and money making - Olga Mitina; Mir Mirsaidov; Natalia Molchanova; Andy Tutrin (PsyArXiv, 2020)

Subjective features of the psilocybin experience that may account for its self-administration by humans: a double-blind comparison of psilocybin and dextromethorphan. - Carbonaro TM; Johnson MW; Griffiths RR (Psychopharmacology, 2020)

Management of overdoses of salvia, kratom, and psilocybin mushrooms: a literature review. - Reinert JP; Colunga K; Etuk A; Richardson V; Dunn RL (Expert review of clinical pharmacology, 2020)

What Psilocybin Taught Me, One Year Later. - Back AL (Journal of palliative medicine, 2020)

4 Psychedelics: therapeutic mechanisms - Robin Carhart-Harris (Journal of Neurology Neurosurgery & Psychiatry, 2020)

Experience of Music Used With Psychedelic Therapy: A Rapid Review and Implications. - O'Callaghan C; Hubik DJ; Dwyer J; Williams M; Ross M (Journal of music therapy, 2020)

Psilocybin Induces Time-Dependent Changes in Global Functional Connectivity. - Preller KH; Duerler P; Burt JB; Ji JL; Adkinson B; Stämpfli P; Seifritz E; Repovš G; Krystal JH; Murray JD; Anticevic A; Vollenweider FX (Biological psychiatry, 2020)

Direct Phosphorylation of Psilocin Enables Optimized cGMP Kilogram-Scale Manufacture of Psilocybin - Kargbo Robert B.; Sherwood Alexander; Walker Andrew; Cozzi Nicholas V.; Dagger Raymond E.; Sable Jessica; O’Hern Kelsey; Kaylo Kristi; Patterson Tura; Tarpley Gary; Meisenheimer Poncho (ACS Omega, 2020)

Scalable Hybrid Synthetic/Biocatalytic Route to Psilocybin. - Fricke J; Kargbo R; Regestein L; Lenz C; Peschel G; Rosenbaum MA; Sherwood A; Hoffmeister D (Chemistry (Weinheim an der Bergstrasse, Germany), 2020)

Metabolic engineering of Saccharomyces cerevisiae for the de novo production of psilocybin and related tryptamine derivatives. - Milne N; Thomsen P; Mølgaard Knudsen N; Rubaszka P; Kristensen M; Borodina I (Metabolic engineering, 2020)

Psilocybin and LSD have no long-lasting effects in an animal model of alcohol relapse. - Meinhardt MW; Güngör C; Skorodumov I; Mertens LJ; Spanagel R (Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology, 2020)

Reviewing the Potential of Psychedelics for the Treatment of PTSD. - Krediet E; Bostoen T; Breeksema J; van Schagen A; Passie T; Vermetten E (The international journal of neuropsychopharmacology, 2020)

Molecular docking and binding interaction between psychedelic drugs and human serum albumin - Hossein Khastar; Kobra Foroughi; Seyed Shahrokh Aghayan; Maryam Yarmohammadi; Moslem Jafarisani (Biotechnologia, 2020)

A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy - Luoma JB. (PsyArXiv, 2020)

How does it feel to be on psilocybin? Dose-response relationships of subjective experiences in humans - Hirschfeld T; Schmidt TT. (bioRxiv, 2020)

A potential role for psilocybin in the treatment of obsessive-compulsive disorder - Edward Jacobs (Journal of Psychedelic Studies, 2020)

Microdosing psychedelics: Demographics, practices, and psychiatric comorbidities. - Rosenbaum D; Weissman C; Anderson T; Petranker R; Dinh-Williams LA; Hui K; Hapke E (Journal of psychopharmacology (Oxford, England), 2020)

Long-term effects of psychedelic drugs: A systematic review. - Aday JS; Mitzkovitz CM; Bloesch EK; Davoli CC; Davis AK (Neuroscience and biobehavioral reviews, 2020)

Development and application of a strategy for analyzing eight biomarkers in human urine to verify toxic mushroom or ricinus communis ingestions by means of hydrophilic interaction LC coupled to HRMS/MS. - Bambauer TP; Wagmann L; Maurer HH; Weber AA; Meyer MR (Talanta, 2020)

Integrating psychotherapy and psychopharmacology: psychedelic-assisted psychotherapy and other combined treatments. - Greenway KT; Garel N; Jerome L; Feduccia AA (Expert review of clinical pharmacology, 2020)

Hallucinogens/psychedelics resurrected as new tools in psychiatric therapy - Rafael G. dos Santos; José Carlos Bouso; Jaime E. C. Hallak (Brazilian Journal of Psychiatry, 2020)

Journal Digest: Home Environment; Postpartum Mental Illness; Placebo in Psychedelic Study; Single Gene Mutation; Topiramate - Nick Zagorski (Psychiatric News, 2020)

Ethics and ego dissolution: the case of psilocybin. - Smith WR; Sisti D (Journal of medical ethics, 2020)

Scoping Review Protocol: Mapping Psilocybin Animal Research - Ron Shore; Nigel Barnim; Katrina Dobson; Sandra McKeown; Éric C. Dumont; Craig Goldie (Queen's University QSpace, 2020)

Scoping Review Protocol: Mapping Psilocybin Therapy Research - Ron Shore; Paul Ioudovski; Sandra McKeown; Éric C. Dumont; Craig Goldie (Queen's University QSpace, 2020)

Nothing Ventured, Nothing Gained: Regulations Cripple Potentially Life-Saving Research of Illicit Substances. - Abbott KL; Gill KS; Flannery PC; Boothe DM; Dhanasekaran M; Pondugula SR (ACS chemical neuroscience, 2020)

Psychedelics, Safety and Clinical Trial Design - Ron Shore (QSpace (Queen's University Library), 2020)

Binding Interactions of Psilocin and Serotonin in the 5-HT2A Receptor - Katie R. Barnes; Stephanie N. Lewis (VTechWorks (Virginia Tech), 2020)

S-Adenosyl-l-Methionine Salvage Impacts Psilocybin Formation in "Magic" Mushrooms. - Demmler R; Fricke J; Dörner S; Gressler M; Hoffmeister D (Chembiochem: a European journal of chemical biology, 2020)

Serotonergic psychedelic drugs LSD and psilocybin reduce the hierarchical differentiation of unimodal and transmodal cortex - Girn M; Roseman L; Bernhardt B; Smallwood J; Carhart-Harris R; Spreng RN. (bioRxiv, 2020)

Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species. - Halberstadt AL; Chatha M; Klein AK; Wallach J; Brandt SD (Neuropharmacology, 2020)

Perceived outcomes of psychedelic microdosing as self-managed therapies for mental and substance use disorders. - Lea T; Amada N; Jungaberle H; Schecke H; Scherbaum N; Klein M (Psychopharmacology, 2020)

Tripping on nothing: placebo psychedelics and contextual factors. - Olson JA; Suissa-Rocheleau L; Lifshitz M; Raz A; Veissière SPL (Psychopharmacology, 2020)

Psychedelics and Psychedelic-Assisted Psychotherapy. - Reiff CM; Richman EE; Nemeroff CB; Carpenter LL; Widge AS; Rodriguez CI; Kalin NH; McDonald WM; the Work Group on Biomarkers; Novel Treatments; a Division of the American Psychiatric Association Council of Research (The American journal of psychiatry, 2020)

Dynamic coupling of whole-brain neuronal and neurotransmitter systems. - Kringelbach ML; Cruzat J; Cabral J; Knudsen GM; Carhart-Harris R; Whybrow PC; Logothetis NK; Deco G (Proceedings of the National Academy of Sciences of the United States of America, 2020)

Klassiske psykedeliske stoffer - inkl. psilocybin og LSD - Morten Hesse (Patienthåndbogen, 2020)

Isness: Using Multi-Person VR to Design Peak Mystical Type Experiences Comparable to Psychedelics - David R. Glowacki; Mark D. Wonnacott; Rachel Freire; Becca R. Glowacki; Ella M. Gale; James E. Pike; Tiu de Haan; Mike Chatziapostolou; Oussama Metatla (Proceedings of the 2020 CHI Conference on Human Factors in Computing Systems, 2020)

Pharmacokinetics of Psilocybin in Normal Adult Volunteers - University of Wisconsin; Madison (ClinicalTrials.gov, 2020)

A review of emerging therapeutic potential of psychedelic drugs in the treatment of psychiatric illnesses. - Chi T; Gold JA (Journal of the neurological sciences, 2020)

Psychedelics for Psychiatric Disorders: More Research Needed - Nick Zagorski (Psychiatric News, 2020)

Global Drug Survey - Petranker R; Anderson T; Maier L; Barratt MJ; Ferris J; Winstock A. (PsyArXiv, 2020)

Global Drug Survey - Rotem Petranker; Thomas Anderson; Larissa Maier; Monica Barratt; Jason Ferris; Adam Winstock (PsyArXiv, 2020)

Psilocybin Therapeutic Research: The Present and Future Paradigm. - Kargbo RB (ACS medicinal chemistry letters, 2020)

Psychedelic Psychiatry's Brave New World. - Nutt D; Erritzoe D; Carhart-Harris R (Cell, 2020)

A single psilocybin dose is associated with long-term increased mindfulness, preceded by a proportional change in neocortical 5-HT2A receptor binding. - Madsen MK; Fisher PM; Stenbæk DS; Kristiansen S; Burmester D; Lehel S; Páleníček T; Kuchař M; Svarer C; Ozenne B; Knudsen GM (European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology, 2020)

One Dose of Psilocybin in Late Adolescence Mitigates Deleterious Effects of Developmental Stress on Cognition and Behavioral Despair in Adult Female Rats - Meghan Hibicke; Charles D. Nichols (The FASEB Journal, 2020)

Direct Analysis of Psilocin and Muscimol in Urine Samples Using Single Drop Microextraction Technique In-Line with Capillary Electrophoresis - Poliwoda Anna; Zielińska Katarzyna; Wieczorek Piotr P. (Molecules, 2020)

Long-Term Analysis of Psilocybin in Cancer Patients With Distress - Richard Simoneaux (Oncology Times, 2020)

Can Psychedelics Radically Change SUD Treatment? - Katie O’Connor (Psychiatric News, 2020)

Psychedelics, but Not Ketamine, Produce Persistent Antidepressant-like Effects in a Rodent Experimental System for the Study of Depression. - Hibicke M; Landry AN; Kramer HM; Talman ZK; Nichols CD (ACS chemical neuroscience, 2020)